First Long Term Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Data from Up to Six Months of Treatment with Aficamten Show Significant and Sustained Reductions in LVOT Gradients with Improvements in Functional Class,.

United statesFadyi malikAhmad masriCytokinetics incorporated nasdaqInternational congressSchool of medicineDivision of cardiovascular medicineEuropean society of cardiologyOregon health science universityResearch developmentSix monthsAficamten show significantSustained reductionsFunctional classLow blood pressure have increased treatmentRandomized evaluation